Chirality, a property where structures have a distinct left- or right-handedness, allows natural semiconductors to move ...
A recent study published in the Journal of Controlled Release demonstrated a novel method for delivering anti-cancer drugs conjugated to modified cell-penetrating peptides across the blood-brain ...
- Conjugation of 2’-O-hexadecyl (C16) to siRNA Enables Therapeutic Silencing of Target Genes Outside the Liver with Infrequent Dosing in Rodents and Non-Human Primates - - In a Mouse Model of ...
Genomic and immunologic profiles of concurrent RB1 and CDKN1A/p21(WAF1) truncating mutations (RW+) in bladder cancer. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This ...
The Molecular Screening and Therapeutics (MoST) Program: A precision medicine framework for biomarker-driven signal-seeking clinical studies for rare cancers. EGFR/CD16A tetravalent bispecific ...
Westlake Therapeutics (Hangzhou) Co. Ltd. and affiliated organizations have reported the design and preclinical characterization of novel erythrocytes conjugated to major histocompatibility complex ...
Conjugated polymer nanoparticles (CPN) have gathered interest recently because of their ability to exhibit a high fluorescence. As such they have become an interesting material for fluorescent probes ...
π-Conjugated molecules and polymers have shown a lot of potential in a broad range of electronic, photonic, spintronic, sensing and biomedical applications. Their properties depend on our ability to ...
The Conjugated Drugs (XDCs) in Oncology Analytical Tool tracks 2,500+ conjugated drugs, 1,200+ organizations, 2,400+ BD&L contacts, and 521 global deals, offering deep insights into ADCs, PDCs, SMDCs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback